IRIS
FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.604
EU - Europa 786
AS - Asia 291
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
SA - Sud America 1
Totale 2.687
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.579
IE - Irlanda 560
CN - Cina 185
SG - Singapore 84
IT - Italia 66
FI - Finlandia 47
DE - Germania 27
CZ - Repubblica Ceca 25
CA - Canada 24
SE - Svezia 16
BE - Belgio 11
GB - Regno Unito 11
JP - Giappone 7
NL - Olanda 6
RU - Federazione Russa 6
HK - Hong Kong 5
IN - India 5
LT - Lituania 4
VN - Vietnam 4
EU - Europa 3
FR - Francia 2
GR - Grecia 2
AT - Austria 1
BR - Brasile 1
EE - Estonia 1
KG - Kirghizistan 1
MU - Mauritius 1
MX - Messico 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 2.687
Salva come PNG Salva come JPEG
Città #
Dublin 560
Chandler 345
Ashburn 252
Boardman 121
Princeton 117
Lawrence 99
Medford 81
Beijing 77
Shanghai 64
Wilmington 64
Singapore 62
Washington 48
Helsinki 47
Brno 22
Toronto 20
New York 18
Norwalk 17
Ann Arbor 16
Pavia 15
Milan 14
Brussels 11
Los Angeles 11
Saint Louis 10
Dallas 7
Tokyo 7
London 6
Munich 6
Redwood City 6
Canyon Country 5
Chicago 5
Falkenstein 5
Houston 5
Seattle 5
Dong Ket 4
Guangzhou 4
Pune 4
Zhengzhou 4
Chengdu 3
Maastricht 3
Malo 3
Olomouc 3
Ottawa 3
Torino 3
Bronx 2
Brunssum 2
Buccinasco 2
Castel del Giudice 2
Ferentino 2
Frankfurt am Main 2
Hong Kong 2
L’Aquila 2
Naples 2
Palo del Colle 2
San Jose 2
Shenzhen 2
Villanuova sul Clisi 2
Wuhan 2
Bishkek 1
Borås 1
Brescia 1
Brugherio 1
Carate 1
Chaozhou 1
Chongqing 1
Clifton 1
Dongguan 1
Fairfield 1
Florence 1
Gatchina 1
Haikou 1
Hanover 1
Johannesburg 1
Leawood 1
Mexico City 1
Monmouth Junction 1
Montreal 1
Mountain View 1
Myszkow 1
Nanchang 1
Nanning 1
Piateda 1
Redmond 1
Santo André 1
Shijiazhuang 1
St Petersburg 1
Taiyuan 1
Tallinn 1
Tappahannock 1
Vienna 1
Vigevano 1
Woodbridge 1
Worthing 1
Xining 1
Yinchuan 1
Totale 2.247
Salva come PNG Salva come JPEG
Nome #
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 58
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 52
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 51
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 49
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG 48
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 47
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 46
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 45
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 43
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 43
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 42
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 42
To a new normal in radiation oncology: looking back and planning forward 42
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 41
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 40
COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS 39
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 39
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 38
The prognostic impact of BIA-derived fat-free mass index in patients with cancer 38
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 37
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center “Blue Sky Radiomics” study on stage III unresectable NSCLC 37
Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG 34
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations 34
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 34
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 34
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy 32
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy 32
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 32
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 32
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 32
Radiotherapy in Pediatric Oncology 31
Current role and future developments of radiotherapy in Hodgkin's lymphoma 31
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start? 30
Brain metastases from lung cancer: Is MET an actionable target? 30
COVID-19: Global radiation oncology's targeted response for pandemic preparedness 30
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 29
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA 29
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 28
Extranodal Marginal Zone Lymphoma 28
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 28
Treatment of metastatic melanoma: a multidisciplinary approach 28
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 28
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 27
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 27
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation 27
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 27
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma 26
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 26
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 25
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 25
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach 25
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 25
Radiomics features as predictive and prognostic biomarkers in NSCLC 25
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 24
A Strategy for Young Members within National Radiation Oncology Societies: the Italian Experience (AIRO Giovani Group) 24
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 23
Emo-linfopatie maligne 22
The "BUONGIORNO" Project: Burnout Syndrome Among Young Italian Radiation Oncologists 22
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review 22
Is clinical radiosensitivity a complex genetically controlled event? 21
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study 21
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 21
New concepts and insights into the role of radiation therapy in extracranial metastatic disease 21
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 21
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 21
Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 20
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists 20
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 20
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 20
Stereotactic radiotherapy for early stage non-small cell lung cancer 19
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 19
Limited stage follicular lymphoma: Current role of radiation therapy 19
Radiation therapy for older patients with brain tumors 18
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 18
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience 18
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 17
Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) 17
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 17
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer 17
Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy 17
Innovative technologies in thoracic radiation therapy for lung cancer 17
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases 17
Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients 17
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 17
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 17
Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group 16
Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases 16
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 15
Intensity Modulated Radiation Therapy and Second Cancer Risk in Adults 15
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 15
Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy 15
Radiomics features as predictive and prognostic biomarkers in NSCLC 14
Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies 14
What do radiation oncologists require for future advancements in lung SBRT? 14
Interim PET and clinical outcome in early stage Hodgkin’s Lymphoma patients treated with combined modality therapy 14
Stereotactic body radiotherapy for early stage lung cancer: History and updated role 14
A young boy with ventricular arrhythmias and thyroid dysgenesis: two genes are not enough? 13
Treatment options in skeletal localizations of hairy cell leukemia: A systematic review on the role of radiation therapy 13
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation 13
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 13
Totale 2.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 0 0 0 2 3 87 27 43 1
2020/202175 0 11 1 7 0 2 6 11 4 1 1 31
2021/2022417 16 0 19 6 7 9 9 29 24 9 68 221
2022/20231.180 136 51 5 75 71 99 5 67 626 4 36 5
2023/2024640 63 69 73 40 74 198 62 12 0 23 1 25
2024/2025345 45 123 34 50 19 62 12 0 0 0 0 0
Totale 2.822